Solid Lipid Nanoparticles: A Modern Approach for the Treatment of Neurodegenerative Diseases
Targeting drugs to the Central nervous system (CNS) for any CNS related disorders has been a herculean task mainly due to the inability of drugs to cross the blood-brain barrier and blood-cerebrospinal fluid barrier. Nanotechnology has been widely adopted to overcome this shortcoming. Solid lipid nanoparticles have been suggested as successful among the different Nano Drug Delivery systems. The increased chances of traversing the blood brain barrier by the lipid components of solid lipid nanoparticles is notable in addition to the other benefits offered by nanoparticles. The current chapter discusses the application of solid lipid nanoparticles in neurodegenerative diseases.
- Madrid Y, Langer LF, Brem H et al (1991) New directions in the delivery of drugs and other substances to the central nervous system. In: August JT, Anders MW, Murad F (eds) Advances in pharmacology. Academic Press, New YorkGoogle Scholar
- Zhan S, Hou D, Ping Q et al (2010) Preparation and entrapment efficiency determination of solid lipid nanoparticles loaded levodopa. Zhongguo Yiyuan Yaoxue Zazhi 30:1171–1175Google Scholar